BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20588287)

  • 1. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?
    Kopp JB
    Kidney Int; 2010 Jul; 78(2):130-3. PubMed ID: 20588287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
    Kopp JB; Winkler CA; Nelson GW
    Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
    Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
    Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal manifestations of patients with MYH9-related disorders.
    Han KH; Lee H; Kang HG; Moon KC; Lee JH; Park YS; Ha IS; Ahn HS; Choi Y; Cheong HI
    Pediatr Nephrol; 2011 Apr; 26(4):549-55. PubMed ID: 21210153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
    Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
    Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
    D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
    Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
    Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
    Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation.
    Toren A; Rozenfeld-Granot G; Heath KE; Amariglio N; Rocca B; Crosson J; Epstein CJ; Laghi F; Landolfi R; Carlsson LE; Argraves S; Bizzaro N; Moxey-Mims M; Brok-Simoni F; Martignetti JA; Greinacher A; Rechavi G
    Am J Hematol; 2003 Dec; 74(4):254-62. PubMed ID: 14635206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.
    Franceschini N; Voruganti VS; Haack K; Almasy L; Laston S; Goring HH; Umans JG; Lee ET; Best LG; Fabsitz RR; MacCluer JW; Howard BV; North KE; Cole SA
    Hum Genet; 2010 Mar; 127(3):295-301. PubMed ID: 19921264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of MYH9-associated nephropathy.
    Bostrom MA; Freedman BI
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1107-13. PubMed ID: 20299374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
    Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
    Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
    Balduini CL; Pecci A; Savoia A
    Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.
    De Rocco D; Zieger B; Platokouki H; Heller PG; Pastore A; Bottega R; Noris P; Barozzi S; Glembotsky AC; Pergantou H; Balduini CL; Savoia A; Pecci A
    Eur J Med Genet; 2013 Jan; 56(1):7-12. PubMed ID: 23123319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.
    Winkler CA; Nelson G; Oleksyk TK; Nava MB; Kopp JB
    Semin Nephrol; 2010 Mar; 30(2):111-25. PubMed ID: 20347641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.
    Kunishima S; Matsushita T; Kojima T; Sako M; Kimura F; Jo EK; Inoue C; Kamiya T; Saito H
    Lab Invest; 2003 Jan; 83(1):115-22. PubMed ID: 12533692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.